85
Views
3
CrossRef citations to date
0
Altmetric
Vaccine Profile

The seasonal influenza vaccine Agriflu®

Pages 1513-1517 | Published online: 09 Jan 2014

References

  • Barker WH. Excess pneumonia and influenza associated hospitalizations during influenza epidemics in the United States. Am. J. Public Health76, 761–765 (1986).
  • Nichol KL, Lind A, Margolis KL et al. The effectiveness of vaccination against influenza in healthy, working adults. N. Engl. J. Med.333(14), 889–893 (1995).
  • Nichol KL, Treanor JJ. Vaccines for seasonal and pandemic influenza. J. Infect. Dis.194(Suppl. 2), S111–S118 (2006).
  • Guidance for Industry. Clinical Data Needed to Support the Licensure of Seasonal Inactivated Influenza Vaccines. US Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research. May 2007.
  • European Committee for Proprietary Medicinal Products. Note for guidance on harmonization of requirements for influenza vaccines, March 1997 (CPMP/BWP/214/96). European Agency for the Evaluation of Medicinal Products, 12 March 1997.
  • Chaloupka I, Schuler A, Marschall M et al. Comparative analysis of six European influenza vaccines. Eur. J. Clin. Microbiol. Infect. Dis.15, 121–127 (1996).
  • Agriflu, package insert. Novartis Vaccines and Diagnostics, Inc., Sienna, Italy.
  • Frey S, Vesikari T, Szymczakiewicz-Multanowska A et al. Clinical efficacy of cell culture-derived and egg-derived inactivated subunit influenza vaccines in healthy adults. Clin. Infect. Dis.51(9), 997–1004 (2010).
  • Agrippal, package insert. Novartis Vaccines and Diagnostics S.r.l., Siena, Italy.
  • Lattanzi M, Rappuoli R. In: The Grand Challenge for the Future. Vaccines for Poverty-Related Diseases from Bench to Field. Kaufmann SHE, Lambert P (Eds). Birkhauser, Basel, Switzerland, 77–98 (2005).
  • Plotkin SA, Plotkin SL. A short history of vaccination. In: Vaccines. Plotkin SA, Orenstein WA (Eds). Saunders, PA, USA (2008).
  • Fiore AE, Shay DK, Broder K et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm. Rep.57, 1–60 (2008).
  • Thompson WW, Shay DK, Weintraub E et al. Influenza-associated hospitalizations in the United States. JAMA292, 1333–1340 (2004).
  • CDC. Estimates of deaths associated with seasonal influenza, United States, 1976–2007. MMWR59(33), 1057–1062 (2010).
  • Molinari NA, Ortega-Sanchez IR, Messonnier ML et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine25, 5086–5096 (2007).
  • Couch RB, Keitel WA, Cate TR. Improvement of inactivated influenza virus vaccines. J. Infect. Dis.176(Suppl. 1), S38–S44 (1997).
  • FluMist, package insert. MedImmune, LLC, MD, USA.
  • Sy CL, Lee SS, Liu MT, Tsai HC, Chen YS. Rapid emergence of oseltamivir resistance. Emerg. Infect. Dis.16(4), 723–725 (2010).
  • Prevention and Control of Influenza with Vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morbidity Mortal. Wkly Rep.59(rr08), 1–62 (2010).
  • Vajo Z, Tamas F, Sinka L, Jankovics I. Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009–2010 influenza season: a multicentre, randomised controlled trial. Lancet375(9708), 49–55 (2010).
  • Vajo Z, Wood J, Kosa L et al. A single-dose influenza A (H5N1) vaccine safe and immunogenic in adult and elderly patients: an approach to pandemic vaccine development. J. Virol.84(3), 1237–1242 (2010).
  • O’Hagan DT, Rappuoli R, De Gregorio E, Tsai T, Del Giudice G. MF59 adjuvant: the best insurance against influenza strain diversity. Expert Rev. Vaccines10(4), 447–462 (2011).
  • Barrett PN, Portsmouth D, Ehrlich HJ. Developing cell culture-derived pandemic vaccines. Curr. Opin. Mol. Ther.12(1), 21–30 (2010).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.